NATURE METHODS, published by NATURE PORTFOLIO, is a prestigious journal at the forefront of publishing influential research in the disciplines of Biochemistry, Biotechnology, Cell Biology, and Molecular Biology. With a high impact factor and its exemplary Q1 rankings across various categories in 2023, this journal epitomizes excellence, providing a vital platform for researchers and professionals to disseminate groundbreaking methodologies and innovative techniques that drive scientific advancement. Established in 2004 and continuing through to 2024, NATURE METHODS encompasses a diverse array of research articles, reviews, and commentary, making it an essential resource for anyone involved in the biological sciences. While the journal is not currently open access, its contributions are invaluable, offering insights that not only elevate academic discourse but also enhance experimental practice and technological application. Its influence and rigorous peer review process ensure it remains a cornerstone in the rapidly evolving fields of biochemistry and molecular biology.

Biology Open, published by COMPANY BIOLOGISTS LTD, serves as a pivotal platform for the dissemination of innovative research within the field of biology. Since its inception in 2012, this open-access journal has established itself in the academic community, achieving Q1 status in Agricultural and Biological Sciences and Q2 ranking in Biochemistry, Genetics, and Molecular Biology as per the 2023 category quartiles. With an impressive Scopus ranking of #62 out of 221 and a 72nd percentile in its primary category, Biology Open continues to attract a diverse array of high-quality studies, fostering accessibility and collaboration across various biological disciplines. The journal's commitment to open-access publishing not only enhances visibility for authors but also promotes the rapid exchange of ideas within the scientific community. Researchers, professionals, and students alike can benefit from its extensive archive of articles, which spans from 2012 to 2024, facilitating knowledge transfer and supporting advancements in biological sciences.

BRITISH JOURNAL OF BIOMEDICAL SCIENCE is a distinguished peer-reviewed journal dedicated to publishing high-quality research in the field of biomedical science. Published by FRONTIERS MEDIA SA, this journal aims to advance knowledge in essential disciplines such as biochemistry, immunology, microbiology, and infectious diseases. Since its inception in 1993, the journal has maintained a solid reputation, achieving notable rankings across multiple Scopus categories, including Q2 in Biochemistry (medical) and Q3 in Clinical Biochemistry and Infectious Diseases. With an emphasis on open access, it facilitates the widespread dissemination of scientific knowledge, ensuring that researchers, professionals, and students can access cutting-edge studies and findings essential for driving innovation in medical and clinical practices. The journal's rigorous editorial standards and commitment to scientific excellence make it an invaluable resource for anyone looking to stay at the forefront of research in biomedical sciences.

eLife is a premier open-access journal that stands at the forefront of biological and medical research, published by eLIFE SCIENCES PUBL LTD in the United Kingdom. Since its inception in 2012, the journal has made significant strides in disseminating high-quality research across various key disciplines, including Biochemistry, Genetics and Molecular Biology, Immunology and Microbiology, and Neuroscience, maintaining a prestigious Q1 quartile ranking in all these fields as of 2023. With an impressive Scopus ranking placing it among the top-tier journals—12th in General Neuroscience, 24th in General Biochemistry, and 8th in General Immunology—eLife is recognized for its impact and influence in shaping research narratives. As an open-access journal, eLife facilitates global access to groundbreaking scientific discoveries, fostering collaboration and innovation among researchers, professionals, and students alike. With a commitment to rigorous peer review and publication excellence, eLife is not just a journal; it is a vital platform contributing to the advancement of life sciences.

Nature Protocols, published by NATURE PORTFOLIO, is a premier academic journal specializing in the dissemination of innovative and practical experimental methodologies in the vast field of biochemistry, genetics, and molecular biology. With an impressive Scopus rank of #5 out of 221 journals and a 97th percentile status, it stands firmly in the Q1 quartile, reflecting its integral role in advancing scientific knowledge. Established in 2006, this journal provides an invaluable resource for researchers and practitioners aiming to refine their experimental techniques, ultimately driving forward the frontiers of life sciences. While currently operating under a subscription model, the journal continues to be a pivotal platform for sharing high-quality, peer-reviewed protocols that facilitate reproducibility and transparency in research. Addressing a global audience from its base in the United Kingdom, Nature Protocols is dedicated to fostering collaboration and innovation, making it indispensable for professionals and students engaged in cutting-edge scientific endeavors.

PLOS BIOLOGY, published by PUBLIC LIBRARY SCIENCE, is a leading open-access journal that has been at the forefront of biological research since its inception in 2003. This high-impact journal (with an impressive Scopus ranking placing it in the top 10% across multiple biological disciplines) aims to disseminate groundbreaking research findings in a variety of fields, including Biochemistry, Genetics, Molecular Biology, Immunology, Microbiology, and Neuroscience. With a commitment to open-access principles, PLOS BIOLOGY ensures that its content is freely available to a global audience, fostering collaboration and innovation among researchers, professionals, and students worldwide. Its Q1 quartile status in 2023 highlights the journal's prestigious standing within the academic community, making it an essential resource for those seeking to stay updated with the latest advancements in biological sciences. The journal's scope extends from 2003 to 2024, reflecting its sustained relevance and impact in driving forward biological discoveries.

INDIAN JOURNAL OF EXPERIMENTAL BIOLOGY, published by the NATL INST SCIENCE COMMUNICATION-NISCAIR, stands as a significant platform for the dissemination of original research in the fields of biochemistry, genetics, and molecular biology, particularly within the context of Indian scientific advancements. With its ISSN 0019-5189 and E-ISSN 0975-1009, the journal has been an essential resource since its inception in 1965, although coverage in prominent databases like Scopus was discontinued in 2018. The journal ranks in the 57th percentile for Biotechnology, as well as in the 27th and 25th percentiles for Molecular Biology and Cell Biology respectively, underscoring its impact and relevance. While currently not an Open Access journal, it continues to provide valuable insights and contributions from researchers and professionals in the growing field of experimental biology. The esteemed contributions published in this journal enhance our understanding of biological processes and foster the development of innovative solutions to contemporary challenges in health and environmental science.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, published by Elsevier, is a pivotal journal in the fields of Molecular Biology and Molecular Medicine, recognized for its high impact factor and robust ranking within Scopus categories, holding prestigious quartiles in Q1 for both disciplines as of 2023. With ISSN 0925-4439 and E-ISSN 1879-260X, this journal fosters cutting-edge research from 1990 to 2025, addressing the critical molecular mechanisms underlying human diseases. Its wide-ranging scope includes original research articles, reviews, and advanced theoretical insights, serving as an essential resource for researchers, clinicians, and students alike. The journal is based in the Netherlands, at RADARWEG 29, 1043 NX AMSTERDAM, and while it does not currently offer an open-access option, it continues to maintain a strong presence in the scientific community, enhancing our understanding of molecular processes in health and disease.

Methods and Protocols is a prestigious open-access journal published by MDPI, focusing on the critical domain of biochemistry, genetics, molecular biology, and biotechnology. Launched in 2018 and based in Basel, Switzerland, the journal provides a vital platform for sharing innovative methodologies and experimental protocols that advance scientific research and development. With an impressive Q2 ranking in multiple categories, including Biochemistry, Genetics and Molecular Biology, and Biotechnology, it fosters a collaborative environment for researchers and professionals to disseminate their findings. With a mission to enhance reproducibility and transparency in scientific inquiry, Methods and Protocols not only serves as an essential resource for academia but also contributes to the practical application of research in various industries. The journal's open-access model ensures that cutting-edge research is accessible to a global audience, thus promoting knowledge sharing and inspiring future innovations within the scientific community.

Bio-protocol is an innovative open-access journal dedicated to the advanced fields of biochemistry, immunology, neuroscience, and plant science, published by BIO-PROTOCOL in the United States since 2023. With an E-ISSN of 2331-8325, this journal serves as a pivotal platform for sharing high-quality methodologies and experimental protocols, enabling researchers, professionals, and students to streamline their experimental workflows and enhance reproducibility in scientific research. In 2023, Bio-protocol achieved notable rankings, placing in the Q2 category for biochemistry, genetics, molecular biology, and immunology, as well as Q3 in neuroscience, reflecting its growing influence and relevance in these fields. The journal offers full open access, ensuring that cutting-edge research is freely available, promoting global collaboration and innovation in the life sciences. Engaging with Bio-protocol positions its readers at the forefront of significant scientific advancements and methodological developments.